<code id='5B7EA08517'></code><style id='5B7EA08517'></style>
    • <acronym id='5B7EA08517'></acronym>
      <center id='5B7EA08517'><center id='5B7EA08517'><tfoot id='5B7EA08517'></tfoot></center><abbr id='5B7EA08517'><dir id='5B7EA08517'><tfoot id='5B7EA08517'></tfoot><noframes id='5B7EA08517'>

    • <optgroup id='5B7EA08517'><strike id='5B7EA08517'><sup id='5B7EA08517'></sup></strike><code id='5B7EA08517'></code></optgroup>
        1. <b id='5B7EA08517'><label id='5B7EA08517'><select id='5B7EA08517'><dt id='5B7EA08517'><span id='5B7EA08517'></span></dt></select></label></b><u id='5B7EA08517'></u>
          <i id='5B7EA08517'><strike id='5B7EA08517'><tt id='5B7EA08517'><pre id='5B7EA08517'></pre></tt></strike></i>

          explore

          explore

          author:hotspot    Page View:51
          After a drawn-out lobbying fight, ARPA-H chose its headquarters: a hub and spokes model, with three central locations in Boston, Texas, and D.C. David L. Ryan/Boston Globe

          WASHINGTON — Cities and states have been clamoring to play host to the Advanced Research Projects Agency for Health since before the agency existed — before, in fact, anyone truly knew what ARPA-H was.

          But the lobbying campaign from universities, business leaders, members of Congress, and big-city mayors is finally over.

          advertisement

          The end came not with a dramatic reveal or a formal ribbon-cutting, but with a largely bureaucratic and anticlimactic announcement that the Biden administration plans to share the wealth. ARPA-H will be housed in a hub-and-spoke model across three major metro areas: The D.C. suburbs; Cambridge, Mass.; and Dallas. Additional “spokes,” the agency announced Tuesday, will be spread across the country at 10 sites spanning from Florida to Alaska.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Neuroscience renaissance leads to new crop of psychiatric drugs
          Neuroscience renaissance leads to new crop of psychiatric drugs

          MikeReddyforSTATOnebyone,thecompaniesbehindZoloft,Prozac,andPaxilsouredonpsychiatry.Itwastheearly200

          read more
          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more

          In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

          AlastairGrant/APLONDON— AstraZenecasaidThursdayitwouldpurchasetheFrenchfirmAmolytPharmainadealworthu